| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:iccc | nasdaq:iccc Shareholders | 13F-HR | 0001907254-22-000002 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | WEALTH EFFECTS LLC | 1907254 | IMMUCELL CORP | COM PAR | 452525306 | 151 | 15650 | SH | SOLE | 0 | 0 | 15650 | May 17th, 2022 01:59AM | May 17th, 2022 01:59AM | ImmuCell | Pharmaceuticals & Biotechnology | |||
| nasdaq:iccc | nasdaq:iccc Shareholders | 13F-HR | 0001567619-22-010973 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | PERRITT CAPITAL MANAGEMENT INC | 1279342 | IMMUCELL CORP COM PAR | COM PAR $0.10 | 452525306 | 352 | 36494 | SH | SOLE | 36494 | 0 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | ImmuCell | Pharmaceuticals & Biotechnology | |||
| nasdaq:iccc | nasdaq:iccc Shareholders | 13F-HR | 0001567619-22-010822 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | BANK OF AMERICA CORP /DE/ | 70858 | IMMUCELL CORP | COM PAR | 452525306 | 5 | 500 | SH | DFND | 02 | 0 | 0 | 500 | May 17th, 2022 01:54AM | May 17th, 2022 01:54AM | ImmuCell | Pharmaceuticals & Biotechnology | ||
| nasdaq:iccc | nasdaq:iccc Shareholders | 13F-HR | 0001567619-22-010822 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | BANK OF AMERICA CORP /DE/ | 70858 | IMMUCELL CORP | COM PAR | 452525306 | 15 | 1532 | SH | DFND | 01 | 1532 | 0 | 0 | May 17th, 2022 01:54AM | May 17th, 2022 01:54AM | ImmuCell | Pharmaceuticals & Biotechnology | ||
| nasdaq:iccc | nasdaq:iccc Shareholders | 13F-HR | 0001420506-22-001062 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | OVERBROOK MANAGEMENT CORP | 1269786 | IMMUCELL CORP | COM PAR | 452525306 | 443 | 45876 | SH | SOLE | 45876 | 0 | 0 | May 17th, 2022 01:50AM | May 17th, 2022 01:50AM | ImmuCell | Pharmaceuticals & Biotechnology | |||
| nasdaq:iccc | nasdaq:iccc Shareholders | 13F-HR | 0001062993-22-012655 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CAPTRUST FINANCIAL ADVISORS | 1512024 | IMMUCELL CORP | COM PAR | 452525306 | 12 | 1200 | SH | SOLE | 1200 | 0 | 0 | May 17th, 2022 01:42AM | May 17th, 2022 01:42AM | ImmuCell | Pharmaceuticals & Biotechnology | |||
| nasdaq:iccc | nasdaq:iccc Shareholders | 13F-HR | 0000950123-22-005967 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | UBS Group AG | 1610520 | IMMUCELL CORP | COM PAR | 452525306 | 15 | 1600 | SH | DFND | 1 | 0 | 0 | 1600 | May 17th, 2022 01:35AM | May 17th, 2022 01:35AM | ImmuCell | Pharmaceuticals & Biotechnology | ||
| nasdaq:iccc | nasdaq:iccc Shareholders | 13F-HR | 0000950123-22-005967 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | UBS Group AG | 1610520 | IMMUCELL CORP | COM PAR | 452525306 | 4 | 366 | SH | DFND | 40 | 0 | 366 | 0 | May 17th, 2022 01:35AM | May 17th, 2022 01:35AM | ImmuCell | Pharmaceuticals & Biotechnology | ||
| nasdaq:iccc | nasdaq:iccc Shareholders | 13F-HR | 0000072971-22-000135 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | WELLS FARGO & COMPANY/MN | 72971 | IMMUCELL CORP | COM PAR | 452525306 | 0 | 34 | SH | DFND | 4 | 34 | 0 | 0 | May 17th, 2022 01:25AM | May 17th, 2022 01:25AM | ImmuCell | Pharmaceuticals & Biotechnology | ||
| nasdaq:iccc | nasdaq:iccc Shareholders | 13F-HR | 0001256484-22-000013 | Mar 31st, 2022 12:00AM | May 13th, 2022 12:00AM | May 13th, 2022 12:00AM | NORTHERN TRUST CORP | 73124 | IMMUCELL CORP | COM | 452525306 | 104 | 10811 | SH | DFND | 01,08 | 0 | 10811 | 0 | May 14th, 2022 01:31AM | May 14th, 2022 01:31AM | ImmuCell | Pharmaceuticals & Biotechnology |